HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $19

Benzinga Newsdesk www.benzinga.com Positive 76.0%

Neg 0% Neu 0% Pos 76%

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $17 to $19.